4 February 2021 - The Therapeutic Goods Administration is conducting a public consultation that seeks to understand potential obstacles and incentives to repurposing of prescription medicines that may influence a sponsor's decision to extend an indication for an existing medicine. 

This will assist in identifying potential regulatory and reimbursement policy options and further consultation may occur.

Read TGA News